Report Categories
View AllRecent Articles
View All
IBRX ImmunityBio reports narrower than expected Q4 2025 loss shares post small gain in todays trading
BHR Braemar H and R misses Q4 2025 EPS estimates by 223 percent shares dip 126 percent today
US Bancorp XLF Q1 2026 Earnings Beat Analyst Consensus and Target Price Assessment
SR Spire Q1 earnings beat disappoints market revenue slide prompts stock decline